Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy

Fig. 1

Plasma LPA concentrations in subgroups of CKD patients and the control group. Levels of LPA are presented in logarithmic scale. * p value for differences between groups in Mann-Whitney U test ** p value for differences between measurements D1 and D2 in Wilcoxon signed-rank test LPA – lysophosphatidic acid, CT –patients treated conservatively, HD D1–patients on hemodialysis before the dialysis (1st donation), HD D1–patients on hemodialysis after the dialysis (2nd donation), PD –patients on peritoneal dialysis, RT D1– renal transplant recipients before the transplantation (1st donation), RT D2– renal transplant recipients after the transplantation (2nd donation), Con – control group

Back to article page